Poly(2-ethyl-2-oxazoline)s (50, 200, and 500 kDa; named as 50, 200 and 500 in the text, respectively) and
hydrocortisone (HC) were purchased from Sigma-Aldrich Irvine, UK) and
Carbopol 974 (highly cross-linked, 28,400–39,400 cP) and
Carbopol 971 (moderately cross-linked, 4000–11,000 cP) were obtained from Lubrizol (Hazelwood, UK). HPLC grade acetonitrile (ACN) was purchased from Teknokroma (Barcelona, Spain).
Sodium chloride,
calcium chloride,
potassium chloride,
sodium hydrogen carbonate and
potassium dihydrogen phosphate were obtained from Merck (Darmstadt, Germany) and used for preparation of artificial saliva fluids. A
Milli-Q water purification system from Millipore (Bedford, MA, USA) was used. The drug
hydrocortisone and internal standard
dexamethasone (DXM) were purchased from Sigma-Aldrich (St Louis, MO, USA). Standard stock solutions of drug and internal standard were prepared in acetonitrile at a concentration of 1000 mg/L. Working solutions were prepared by dilution from stock solutions with the mix of excipients and polymers used in the pharmaceutical formulation of tablets (magnesium state, poly(2-ethyl-2-oxazoline) and Carbopols 974 and
Carbopol 971) in artificial saliva.
Ruiz-Rubio L., Alonso M.L., Pérez-Álvarez L., Alonso R.M., Vilas J.L, & Khutoryanskiy V.V. (2018). Formulation of Carbopol®/Poly(2-ethyl-2-oxazoline)s Mucoadhesive Tablets for Buccal Delivery of Hydrocortisone. Polymers, 10(2), 175.